Exhibit 99.1
CONSENT TO BE NAMED
I hereby confirm my consent to be named as a director of Oyster Point Pharma, Inc. (the “Company”), in the Registration Statement on FormS-1 filed by the Company with the Securities and Exchange Commission, including any and all amendments and post-effective amendments thereto and any amendments filed under Rule 462(b) (collectively, the “Registration Statement”). This consent may be filed as an exhibit to the Registration Statement.
DATED: October 4, 2019 | /s/ Aimee Weisner, J.D. | |||||
Aimee Weisner, J.D. |